© 2012 eurointervention. all rights reserved. eurointervention 2012;8:87-93 impact of age on...

© 2012 EuroIntervention. All rights reserved. EuroIntervention 2012;8:87-93 Impact of age on clinical outcomes after everolimus-eluting and paclitaxel- eluting stent implantation: pooled analysis from the SPIRIT III and SPIRIT IV clinical trials

Upload: jonathan-copeland

Post on 28-Dec-2015

212 views

Category:

Documents

0 download

Report

Download

Embed Size (px):

TRANSCRIPT

012

Euro

Inte

rven

tion.

All

right

s re

serv

ed.

EuroIntervention 2012;8:87-93Impact of age on clinical outcomes after everolimus-eluting and paclitaxel-eluting stent implantation: pooled analysis from the SPIRIT III and SPIRIT IV clinical trials

012

Euro

Inte

rven

tion.

All

right

s re

serv

ed.

EuroIntervention 2012;8:87-93Impact of age on clinical outcomes after everolimus-eluting and paclitaxel-eluting stent implantation: pooled analysis from the SPIRIT III and SPIRIT IV clinical trials

012

Euro

Inte

rven

tion.

All

right

s re

serv

ed.

EuroIntervention 2012;8:87-93Impact of age on clinical outcomes after everolimus-eluting and paclitaxel-eluting stent implantation: pooled analysis from the SPIRIT III and SPIRIT IV clinical trials

012

Euro

Inte

rven

tion.

All

right

s re

serv

ed.

EuroIntervention 2012;8:87-93Impact of age on clinical outcomes after everolimus-eluting and paclitaxel-eluting stent implantation: pooled analysis from the SPIRIT III and SPIRIT IV clinical trials

012

Euro

Inte

rven

tion.

All

right

s re

serv

ed.

EuroIntervention 2012;8:87-93Impact of age on clinical outcomes after everolimus-eluting and paclitaxel-eluting stent implantation: pooled analysis from the SPIRIT III and SPIRIT IV clinical trials

012

Euro

Inte

rven

tion.

All

right

s re

serv

ed.

EuroIntervention 2012;8:87-93Impact of age on clinical outcomes after everolimus-eluting and paclitaxel-eluting stent implantation: pooled analysis from the SPIRIT III and SPIRIT IV clinical trials

Real-WorldThree-YearClinicalOutcomesofBiolimus-Eluting

Drug -eluting stents Are they all equal? · Kandzari D.Kandzari D.et.al. “ et.al. “Comparison of zotarolimusComparison of zotarolimus--eluting and sirolimuseluting and sirolimus--eluting

A new polymer-free drug-eluting stent with nanocarriers eluting sirolimus from stent-plus-balloon compared with bare-metal stent and with biolimus A9 eluting stent in porcine coronary

Comparison of the Efficacy and Safety of Zotarolimus-Eluting Stent versus Sirolimus-Eluting Stent and PacliTaxel- Eluting Stent for Coronary Lesions: The

Journal of American Science 2012;8(6) ... · Journal of American Science 2012;8(6) 816 [email protected]

Journal of American Science, 2012;8(3) ... · PDF fileJournal of American Science, 2012;8(3) ... The bronchioles showed hyperplasia and desquamation of its lining epithelia in the

Comparison of the ABSORBTM Everolimus Eluting ......Comparison of the ABSORBTM Everolimus Eluting Bioresorbable Vascular Scaffold System With a Drug- Eluting Metal Stent (XienceTM)

Bioabsorbable Drug-Eluting Cardiac Stent Analysis

Drug-Eluting Coronary-Artery Stents.pdf

Drug-eluting stents

Drug eluting stents will solve the problem! Against JUNE...Commeau Cardiovasc Interv Radiol 2006 29 66 86.4 @ 12M 96.0 @ 12M Siablis J Endovasc Ther 2007 30 30 100 @ 6M-Scheinert EuroIntervention

Volume 5, No. 6 DRUG-ELUTING TECHNOLOGIES · advent of drug-eluting technologies, including drug-eluting stents (DESs) and drug-coated balloons (DCBs), that has rapidly influenced